Results 231 to 240 of about 12,599,414 (356)

Characterizing heterogeneity in Alzheimer's disease progression: a semiparametric model. [PDF]

open access: yesSci Rep
Gelir F   +8 more
europepmc   +1 more source

Vaccinations and steroids in MS: effects on disease progression and mood

open access: gold, 1999
H. Kollegger   +5 more
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

open access: yesMolecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach   +8 more
wiley   +1 more source

Molecular Follow-Up of Disease Progression and Interferon Therapy in Chronic Myelocytic Leukemia [PDF]

open access: bronze, 1997
Dina Ben‐Yehuda   +10 more
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

open access: yesMolecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche   +8 more
wiley   +1 more source

Potassium homeostasis during disease progression of Alzheimer's disease. [PDF]

open access: yesJ Physiol
Samokhina E   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy